282 related articles for article (PubMed ID: 6590073)
1. [Determination of plasma levels of apolipoprotein E and of HDL-cholesterol in gouty patients].
Frati E; Castagna ML; Bacarelli M; Giordano N; Fioravanti A; Pucci G; Marcolongo R
Boll Soc Ital Biol Sper; 1984 May; 60(5):1063-9. PubMed ID: 6590073
[TBL] [Abstract][Full Text] [Related]
2. [Plasma levels of apolipoprotein and HDL-cholesterol in patients with rheumatoid arthritis].
Frati E; Castagna ML; Bacarelli MR; Fioravanti A; Giordano N; Taddeo A; Marcolongo R
Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1791-6. PubMed ID: 6525299
[TBL] [Abstract][Full Text] [Related]
3. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol distribution among lipoprotein fractions in patients with gout and normal controls.
Jacobelli S; Arteaga A; Bidegain F
J Rheumatol; 1986 Aug; 13(4):774-7. PubMed ID: 3464758
[TBL] [Abstract][Full Text] [Related]
5. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
[No Abstract] [Full Text] [Related]
6. Changes in plasma apolipoproteins A-I, A-II, and B, and lipoprotein cholesterol after jejunoileal bypass.
Goldberg RB; Weinberg RB; Landau RL
Gastroenterology; 1983 Apr; 84(4):732-6. PubMed ID: 6402411
[TBL] [Abstract][Full Text] [Related]
7. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
[TBL] [Abstract][Full Text] [Related]
8. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
Kushwaha RS; Chait A; Hazzard WR
J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
[TBL] [Abstract][Full Text] [Related]
9. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
[TBL] [Abstract][Full Text] [Related]
10. [Apolipoproteins A and B in cerebrovascular diseases].
Bruck J; Fischer M; Sluga E; Tschabitscher H
Nervenarzt; 1985 Feb; 56(2):89-93. PubMed ID: 3982568
[TBL] [Abstract][Full Text] [Related]
11. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
12. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
13. [Lipid metabolism disorders in patients with retinal artery occlusions].
Fellinger C; Schmut O; Hofmann H
Klin Monbl Augenheilkd; 1984 Feb; 184(2):109-11. PubMed ID: 6716886
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
[TBL] [Abstract][Full Text] [Related]
15. [Concentration of lipids and apolipoproteins A-I, A-II and E in blood plasma of men with chronic alcoholism].
Triufanov VF; Usatenko MS; Bokiĭ IV
Vopr Med Khim; 1981; 27(3):397-402. PubMed ID: 6792781
[TBL] [Abstract][Full Text] [Related]
16. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
[TBL] [Abstract][Full Text] [Related]
17. Serum lipoproteins, apolipoproteins and intravenous fat tolerance in young athletes.
Ericsson M; Johnson O; Tollin C; Furberg B; Backman C; Angquist K
Scand J Rehabil Med; 1982; 14(4):209-12. PubMed ID: 7178868
[TBL] [Abstract][Full Text] [Related]
18. [Plasma lipoproteins and apolipoproteins. Value of their determination in the detection of coronary atherosclerosis. Comparison with data supplied by coronarography].
Fruchart JC; Bertrand M; Parra H; Gentilini JL; Boniface B; Boniface M
Nouv Presse Med; 1982 Nov; 11(47):3491-4. PubMed ID: 6818524
[TBL] [Abstract][Full Text] [Related]
19. [Plasma levels of lipids, lipoproteins and apolipoproteins affected by endogenous testosterone].
Zhao S; Li X; Wang Z
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(3):299-301. PubMed ID: 10681765
[TBL] [Abstract][Full Text] [Related]
20. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
Breier C; Lisch HJ; Drexel H; Braunsteiner H
Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
